- Targeted stakeholdersMay reduce medically unnecessary delays through physician-led authorization decisions.
- Targeted stakeholdersIncreases transparency by requiring online posting of criteria and approval/denial statistics.
- CommunitiesPromotes alignment of utilization rules with nationally recognized and community standards of care.
Reducing Medically Unnecessary Delays in Care Act of 2025
Referred to the Committee on Ways and Means, and in addition to the Committee on Energy and Commerce, for a period to be subsequently determined by the Speaker, in each case for c…
The bill requires that Medicare prior authorization and adverse determinations be based on medical necessity and written clinical criteria, with physician input and regular updates.
It mandates that determinations be made by state-licensed, board-certified (or eligible) physicians in the same specialty, requires public website posting of criteria and statistics, 60-day prior notice for new rules, and annual review of criteria.
Plans may not deny services solely because no independent evidence-based standard exists.
Technocratic reform with some bipartisan appeal but industry opposition, implementation costs, and Senate hurdles reduce chances.
Relative to its intended legislative type, this bill is a substantive policy change that imposes specific contract requirements on Medicare administrative contractors, Medicare Advantage organizations, and prescription drug plan sponsors to govern prior authorization and adverse determinations. It provides detailed content requirements and transparency obligations but leaves several implementation, fiscal, and enforcement elements unspecified.
Liberal emphasizes patient access and clinician control over denials
Who stands to gain, and who may push back.
- Targeted stakeholdersLikely increases administrative costs for contractors, plans, and Medicare oversight.
- Targeted stakeholdersMay strain supply of appropriately board-certified physicians available to perform determinations.
- Targeted stakeholdersCould slow decision turnaround if specialist physician reviewers are not immediately available.
Why the argument around this bill splits.
Liberal emphasizes patient access and clinician control over denials
Likely broadly supportive because the bill returns clinical decision-making authority to physicians and increases transparency and patient access.
Supports evidence- and community-standard-based criteria but will seek stronger enforcement and protections against managed-care gaming.
Generally favorable to physician decision-making and transparency, but cautious about implementation costs and operational effects.
Will look for evidence on administrative burdens, timelines, and program costs before full endorsement.
Skeptical of federal mandates on plan operations despite support for clinician-led decisions.
Concerned this imposes rigid staffing and process requirements that increase costs and reduce managed-care flexibility.
The path through Congress.
Reached or meaningfully advanced
Reached or meaningfully advanced
Still ahead
Still ahead
Still ahead
Technocratic reform with some bipartisan appeal but industry opposition, implementation costs, and Senate hurdles reduce chances.
- Absent official cost estimate or CBO score
- Potential opposition from insurers and plan sponsors
Recent votes on the bill.
No vote history yet
The bill has not accumulated any surfaced votes yet.
Go deeper than the headline read.
Liberal emphasizes patient access and clinician control over denials
Technocratic reform with some bipartisan appeal but industry opposition, implementation costs, and Senate hurdles reduce chances.
Relative to its intended legislative type, this bill is a substantive policy change that imposes specific contract requirements on Medicare administrative contractors, Medicare Advantage organizations, and prescription…
Go beyond the headline summary with full stakeholder mapping, legislative design analysis, passage barriers, and lens-by-lens tradeoff breakdowns.